Related Experiment Videos
Intravesical therapy in superficial bladder cancer
J A Witjes1, P F Mulders, F M Debruyne
1Department of Urology, University Hospital, Nijmegen, The Netherlands.
Urology
|February 1, 1994
Summary
Predicting superficial bladder cancer behavior is possible on a group level using identified characteristics. While individual prediction remains challenging, treatment options like bacillus Calmette-Guerin (BCG) can influence outcomes.
Area of Science:
- Urology
- Oncology
Background:
- Superficial bladder cancer (SBC) requires accurate prediction of tumor behavior for effective management.
- Identifying prognostic factors is crucial for tailoring treatment strategies.
Purpose of the Study:
- To determine characteristics of superficial bladder cancer for predicting tumor behavior.
- To establish prognostic factors for SBC patient groups.
Main Methods:
- Analysis of 1,745 patients with primary superficial bladder cancer.
- Evaluation of disease and patient characteristics to identify predictive factors.
Main Results:
- Identified characteristics allow for population description and prognostic factor determination.
- Tumor behavior prediction is feasible at a group level, but individual prediction is limited.
- Three treatment options exist: follow-up, intravesical chemotherapy, or bacillus Calmette-Guerin (BCG) instillations.
Conclusions:
- Intravesical BCG demonstrates superiority over chemotherapy for SBC, despite potential side effects.
- Intravesical BCG can influence the natural history of superficial bladder cancer, delaying progression and improving survival.
- Treatment decisions for SBC include observation, chemotherapy, or BCG, based on prognostic factors.